secwatch / observer
8-K filed February 10, 2023, 6:59 PM ET ticker PURE CIK 0001006028
other confidence high sentiment neutral materiality 0.15

Pure Bioscience shareholders elect seven directors, ratify auditor, approve exec compensation at annual meeting

PURE BIOSCIENCE, INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PURE BIOSCIENCE, INC. shareholders approved Ratification of the appointment of Weinberg & Company, P.A. as independent registered public accounting firm for fiscal year ending July 31, 2023 at the 2023-02-08 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-02-08
Exact text from the filing
(2) Ratification of Auditors. The Company’s stockholders ratified the appointment of Weinberg & Company, P.A., with the approval of 99.87% of the votes cast, as the Company’s independent registered public accounting firm for the fiscal year ending July 31, 2023. The following table shows the tabulation of the votes cast For and Against this proposal as well as the Abstentions submitted on this proposal: For Against Abstentions 65,354,828 78,962 532,202
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PURE BIOSCIENCE, INC. shareholders approved Election of Directors at the 2023-02-08 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-02-08
Exact text from the filing
(1) Election of Directors. The Company’s stockholders elected each of Tom Y. Lee, CPA, Ivan Chen, Tom Myers, Kristin A. Taylor, David M. Rendall, Robert Bartlett, and Bernard Blotner with the approval of 96.67%, 99.19%, 98.33%, 96.60%, 97.38%, 97.35% and 97.34%, of the votes cast, respectively, to hold office until next year’s Annual Meeting of Stockholders and until their respective successors are elected and qualified. The following table shows the tabulation of the votes cast For and Withheld with respect to the election of each of the director nominees as well as the Broker Non-Votes submitted for each director nominee: Director For Withheld Broker Non-Votes Tom Y. Lee, CPA 52,417,512 1,805,553 11,742,927 Ivan Chen 53,783,287 439,778 11,742,927 Tom Myers 53,317,145 905,920 11,742,927 Kristin A. Taylor 52,377,326 1,845,739 11,742,927 David M. Rendall 52,804,580 1,418,485 11,742,927 Robert Bartlett 52,786,761 1,436,304 11,742,927 Bernard Blotner 52,782,415 1,440,650 11,742,927
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PURE BIOSCIENCE, INC. shareholders approved Advisory vote on the compensation of named executive officers (say-on-pay) at the 2023-02-08 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-02-08
Exact text from the filing
(3) Executive Compensation. The Company’s stockholders, on a non-binding, advisory basis, approved the compensation of the Company’s named executive officers, with the approval of 96.84% of the votes cast, as disclosed in the Proxy Statement. The following table shows the tabulation of the votes cast For and Against this proposal as well as the Abstentions and Broker Non-Votes submitted on this proposal: For Against Abstentions Broker Non-Votes 49,699,924 1,617,819 2,905,322 11,742,927
View on SEC.gov

Browse all shareholder votes →

PURE BIOSCIENCE, INC. filing history →

Source: SEC EDGAR
accession 0001493152-23-004296
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.